Z
603079
vs
S
Shanghai Composite
Over the past 12 months, Zhejiang Shengda Bio-Pharm Co Ltd has outperformed Shanghai Composite, delivering a return of +34% compared to the Shanghai Composite's +23% growth.
Stocks Performance
603079 vs Shanghai Composite
Performance Gap
603079 vs Shanghai Composite
Performance By Year
603079 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Zhejiang Shengda Bio-Pharm Co Ltd
Glance View
Zhejiang Shengda Bio-Pharm Co., Ltd. engages in the research, development, production, and sale of food and feed additives. The company is headquartered in Taizhou, Zhejiang and currently employs 1,114 full-time employees. The company went IPO on 2017-08-23. Its vitamin products mainly include biotin and folic acid. Its biological preservative products mainly include natamycin and nisin. The firm distributes its products in domestic market and to overseas markets.